{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:47:06Z","timestamp":1789685226363,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.euroneuro.2012.05.017","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T13:31:25Z","timestamp":1343309485000},"page":"305-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania"],"prefix":"10.1016","volume":"23","author":[{"given":"J.M.","family":"Goikolea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Colom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Capapey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Undurraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2012.05.017_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra035354","article-title":"Bipolar disorder","volume":"351","author":"Belmaker","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v67n0116","article-title":"Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials","volume":"67","author":"Cavazzoni","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2012.05.017_bib4","first-page":"CD004362","article-title":"Haloperidol alone or in combination for acute mania","volume":"19","author":"Cipriani","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib5","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib6","series-title":"Cochrane collaboration handbook version 4.0 (updated July 2000)","author":"Clarke","year":"2000"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Der-Simonian","year":"1986","journal-title":"Control Clin. Trials"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib8","unstructured":"Goikolea, J.M., Colom, F., Torres, I., Capapey, J., Valent\u00ed, M., Undurraga, J., Grande, I., Sanchez-Moreno, J, Vieta, E. Lower rate of depressive switch following antimanic treatment with second generation antipsychotics versus haloperidol. J. Affect. Disord., in press."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib9","series-title":"Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression","author":"Goodwin","year":"2007"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib11","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib12","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","article-title":"Chapter 8: assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3928\/0048-5713-19920201-13","article-title":"Advances in the treatment of mania and related disorders: a reappraisal","volume":"22","author":"Janicak","year":"1992","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1034\/j.1399-5618.2000.020106.x","article-title":"Pharmacologic loading in the treatment of acute mania","volume":"2","author":"Keck","year":"2000","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study","volume":"112","author":"Keck","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/ebmh.14.1.17","article-title":"People with bipolar disorder and comorbid substance abuse are six times more likely to be convicted of violent crime than the general population","volume":"14","author":"Large","year":"2011","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4088\/JCP.v69n0610","article-title":"Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","article-title":"Quetiapine or haloperidol as monotherapy for bipolar mania: a 12 weeks double blind, randomised, parallel group, placebo controlled trial","volume":"15","author":"McIntyre","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib19","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib20","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1176\/ajp.145.11.1455","article-title":"Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia","volume":"145","author":"Nasrallah","year":"1988","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib21","unstructured":"Nivoli, A.M., Murru, A., Goikolea, J.M., Crespo, J.M., Montes, J.M., Gonz\u00e1lez-Pinto, A., Garc\u00eda-Portilla, P., Bobes, J., S\u00e1iz-Ruiz, J., Vieta, E.. New treatment guidelines for acute bipolar mania: a critical review. J. Affect. Disord., in press."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0924-9338(02)00680-6","article-title":"Manic episodes: the direct cost of a three-month period following hospitalisation","volume":"17","author":"Oli\u00e9","year":"2002","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.euroneuro.2011.09.008","article-title":"Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder","volume":"22","author":"Popovic","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib24","series-title":"Version 4.2 for Windows","author":"Review Manager, (RevMan) [Computer program]","year":"2003"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib25","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"Am. J. Psychatry"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archpsyc.64.4.442","article-title":"Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials","volume":"64","author":"Scherk","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib27","first-page":"176","article-title":"Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial","volume":"21","author":"Segal","year":"1998","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2004.06.003","article-title":"Acute and continuation risperidone monotherapy in bipolar mania: a 3 week placebo controlled trial followed by a 9 week double blind trial of risperidone and haloperidol","volume":"15","author":"Smulevich","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2012.05.017_bib29","first-page":"38","article-title":"Antipsychotic agents and bipolar disorder","volume":"59","author":"Tohen","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","article-title":"Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group","volume":"57","author":"Tohen","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib31","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","article-title":"A 12-week, double-blind comparison of olanzapine vs. haloperidol in the treatment of acute mania","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.euroneuro.2012.05.017_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-5618.2009.00710.x","article-title":"Antipsychotic agents in the treatment of bipolar mania","volume":"11","author":"Tohen","year":"2009","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.187.3.235","article-title":"Effectiveness of aripiprazole vs. haloperidol in acute bipolar mania: double blind, randomised, comparative 12 week trial","volume":"187","author":"Vieta","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.euroneuro.2012.05.017_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1399-5618.2005.00212.x","article-title":"Atypical antipsychotics: newer options for mania and maintenance therapy","volume":"7","author":"Vieta","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jad.2009.02.007","article-title":"Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM)","volume":"118","author":"Vieta","year":"2009","journal-title":"J Affect. Disord."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0269881108099418","article-title":"Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study","volume":"24","author":"Vieta","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib37","first-page":"26","article-title":"Head to head comparisons as an alternative to placebo-controlled trials","author":"Vieta","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2012.05.017_bib39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.bp.108.049965","article-title":"Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study","volume":"194","author":"Young","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials","volume":"36","author":"Yildiz","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.05.017_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.161.1.169","article-title":"Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients","volume":"161","author":"Zarate","year":"2004","journal-title":"Am. J. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:50:16Z","timestamp":1760377816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X12001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0924977X12001526"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.05.017","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}